Blockchain Registration Transaction Record

Lexaria Bioscience Releases Positive Findings from Applied Research Program with NRC

Lexaria Bioscience releases positive findings from applied research program with NRC, evaluating DehydraTECH processed semaglutide and its potential impact on drug delivery and bioabsorption.

This news matters because it highlights the positive findings from Lexaria Bioscience's research program, shedding light on the molecular properties of DehydraTECH-processed pure semaglutide in comparison to the commercially available semaglutide formulation Rybelsus. The findings show efficient release of semaglutide in the simulated gastric fluid environment, suggesting potential advancements in drug-delivery platforms and oral bioabsorption.